1.Prevalence of Exudative Age-related Macular Degeneration and Projections of the Cost of Ranibizumab in Korea
Sunyoung RYU ; Dong Wook KIM ; Tyler Hyungtaek RIM ; Eun Jee CHUNG ; Jiwon KIM
Journal of the Korean Ophthalmological Society 2019;60(3):253-260
PURPOSE: To analyze the incidence and prevalence of exudative age-related macular degeneration (AMD) and to predict the future AMD populations and health expenditures of intravitreal ranibizumab injection. METHODS: From 2010 to 2014, the National Health Insurance claims data were used to estimate the incidence and prevalence change of exudative AMD, according to demographic characteristics (year, sex, residence, and age). Based on the above results and changes in future population distribution, we estimated the AMD population by 2030. Considering the cost of Intravitreal ranibizumab injection from 2010 to 2014, we predicted the future health expenditure for AMD. RESULTS: The incidence and prevalence of exudative AMD increased from 14.04 and 295.11 per 100,000 populations in 2010 to 14.25 and 580.71 in 2014, respectively. The prevalence rate was higher in men and showed a large increase over 70 years of age. The ranibizumab was prescribed 13 times per person in average, and the amount consumed increased as the number of insurance coverage increased from 2013. Future AMD populations are predicted to reach 557,007 in 2030 from 146,871 in 2014. As a result, the cost of intravitreal ranibizumab injection is expected to increase from 83.6 billion won in 2014 to 171.7 billion won in 2030. CONCLUSIONS: The increase in medical expenses for AMD is expected due to social aging. Therefore, we need policies to secure medical resources and expand insurance indications.
Aging
;
Demography
;
Health Expenditures
;
Humans
;
Incidence
;
Insurance
;
Insurance Coverage
;
Korea
;
Macular Degeneration
;
Male
;
National Health Programs
;
Prevalence
;
Ranibizumab
2.Bilateral Rhegmatogenous Retinal Detachments after Systemic Pazopanib Treatment
Sun Young RYU ; Soo Jung HONG ; Eun Jee CHUNG
Journal of the Korean Ophthalmological Society 2019;60(5):491-495
PURPOSE: A case of bilateral rhegmatogenous retinal detachment is reported after pazopanib treatment of a patient with breast angiosarcoma. CASE SUMMARY: A 53-year-old female presented with bleeding in a right breast mass prior to an emergency room visit. She was diagnosed with metastatic breast angiosarcoma after a breast mass biopsy. She was treated with paclitaxel and radiation therapy. Systemic pazopanib treatment was added to treat lung metastasis. After 3 weeks, she felt sudden floaters in her right eye. In her fundus examination, there was vitreous hemorrhage, but no retinal detachment was noted. Five weeks later, she visited the clinic for a bilateral temporal visual field defect. A fundus examination showed bilateral retinal detachments with superonasal retinal tears. Both the patient and her family did not want surgery for her systemic condition because of her terminal cancer. CONCLUSIONS: Retinal detachment has been reported as a rare complication after systemic pazopanib treatment, but there has been no previous report in the Republic of Korea, therefore this is the first case of bilateral retinal detachments after systemic pazopanib treatment.
Biopsy
;
Breast
;
Emergency Service, Hospital
;
Female
;
Hemangiosarcoma
;
Hemorrhage
;
Humans
;
Lung
;
Middle Aged
;
Neoplasm Metastasis
;
Paclitaxel
;
Republic of Korea
;
Retinal Detachment
;
Retinal Perforations
;
Retinaldehyde
;
Visual Fields
;
Vitreous Hemorrhage
3.Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
Ji Won WOO ; Yul Ri CHUNG ; Soomin AHN ; Eunyoung KANG ; Eun Kyu KIM ; Se Hyun KIM ; Jee Hyun KIM ; In Ah KIM ; So Yeon PARK
Journal of Breast Cancer 2019;22(3):439-452
PURPOSE: There is cumulative evidence that changes in biomarker status occur frequently during the metastatic progression of breast cancer and affect treatment response. The purpose of this study was to evaluate the frequency of biomarker changes in metastatic breast cancer (MBC) and its impact on prognosis. METHODS: A total of 152 patients diagnosed with MBC at the time of initial diagnosis or during post-surgical follow-up were included. Changes in biomarker status in MBCs, their frequency according to various metastatic sites, tumor characteristics, and their association with patient survival were analyzed. RESULTS: Estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 status changed in 9 (6.0%), 40 (26.3%), 12 (7.9%), and 29 (19.1%) patients, respectively. ER, PR, and HER2 mainly showed positive to negative conversion, whereas Ki-67 changed mostly from a low to high index. There were no differences in the frequencies of biomarker changes according to the metastatic sites. As for ER and HER2, cases with negative conversion showed low expression levels in the primary tumor. Survival analyses indicated that a positive to negative conversion of ER was an independent poor prognostic factor in patients with primary ER-positive breast cancer. CONCLUSION: Changes in biomarker status are not rare, and usually occur in an unfavorable direction in breast cancer metastases. Negative conversion of ER status is a predictor of poor prognosis. Thus, it is beneficial to evaluate changes in biomarker status in MBC not only for the purpose of determining treatment options but also for prognostication of patients.
Biomarkers
;
Breast Neoplasms
;
Breast
;
Diagnosis
;
Estrogens
;
Follow-Up Studies
;
Humans
;
Neoplasm Metastasis
;
Prognosis
;
Receptor, Epidermal Growth Factor
;
Receptors, Progesterone
4.Estimated Incidence and Cost Projections of Cataract Surgery in the Republic of Korea
Sun Young RYU ; Jiwon KIM ; Jung Hwa HONG ; Eun Jee CHUNG
Journal of the Korean Ophthalmological Society 2019;60(9):829-834
PURPOSE: We sought to predict the future incidence and health expenditures of cataract surgery in the Republic of Korea. METHODS: From 2011 to 2015, National Health Insurance claims data were used to estimate the incidence and prevalence changes of cataract surgery according to demographic characteristics (year, sex, residence, and age). Based on the above results and changes in future population distribution, we estimated the incidence of cataract surgery by 2030. Considering the cost of cataract surgery from 2011 to 2015, we also predicted future health expenditures for cataract surgery. RESULTS: A total of 2,236,107 eyes of 1,591,176 patients underwent cataract surgery from 2011 to 2015. The total number of operated eyes per year increased, from 427,729 to 492,700 (+15%), and the number of patients increased from 306,710 to 346,056 (+12%) from 2011 to 2015. The cost of cataract surgery reimbursed by the National Health Insurance Service (NHIS) increased from 408,307,530,900 won ($360 million) to 449,334,367,080 won ($399 million) (+9%). The future prevalence of cataract surgery was predicted to reach 562,003 in 2030 from 346,056 in 2015. The cost of cataract surgery is expected to increase from 449 billion won ($399 million) in 2015 to 641 billion won ($570 million) in 2030. CONCLUSIONS: Cataract surgery and medical expenses will increase due to social aging. Therefore, we need policies to secure medical resources and expand insurance indications.
Aging
;
Cataract
;
Demography
;
Health Expenditures
;
Humans
;
Incidence
;
Insurance
;
National Health Programs
;
Prevalence
;
Republic of Korea
5.Immediate Umbilical Reconstruction after a Mohs Micrographic Surgery for Primary Cutaneous Adenoid Cystic Carcinoma Arising in the Umbilicus
Jee Eun KIM ; Mi Ryung ROH ; Kee Yang CHUNG
Annals of Dermatology 2019;31(6):669-672
Adenoid cystic carcinoma (ACC) is a malignant neoplasm of glands commonly occurs in salivary glands. Primary cutaneous adenoid cystic carcinoma (PCACC) is a rare form of ACC that primarily presents on the skin. Herein, we represent a rare case of PCACC occurred in the umbilicus in a 66-year-old Korean male patient. The patient visited our center with erythematous indurated patch on the umbilicus diagnosed as ACC by incisional biopsy at another center. The diagnosis of PCACC was confirmed by additional histopathologic examination and imaging study. We proceeded Mohs micrographic surgery and reconstructed umbilicus with tacked purse string suture. Local recurrence and distant metastasis were not observed during 30-month follow-up. We report this rare case of PCACC on the umbilicus so that dermatologist can aware of the rare disease. Furthermore, we recommend MMS and tacked purse string suture as effective methods for treatment of PCACC and immediate umbilical reconstruction.
Adenoids
;
Aged
;
Biopsy
;
Carcinoma, Adenoid Cystic
;
Diagnosis
;
Follow-Up Studies
;
Humans
;
Male
;
Mohs Surgery
;
Neoplasm Metastasis
;
Rare Diseases
;
Recurrence
;
Salivary Glands
;
Skin
;
Sutures
;
Umbilicus
6.A Comparison Study of Cilostazol and Aspirin on Changes in Volume of Cerebral Small Vessel Disease White Matter Changes: Protocol of a Multicenter, Randomized Controlled Trial
Hyun Jeong HAN ; Byeong C KIM ; Young Chul YOUN ; Jee Hyang JEONG ; Jong Hun KIM ; Jae Hong LEE ; Kee Hyung PARK ; Kyung Won PARK ; Eun Joo KIM ; Mi Sun OH ; Yong S SHIM ; Hyun Young PARK ; Bora YOON ; Soo Jin YOON ; Soo Jin CHO ; Key Chung PARK ; Duk L NA ; Sun Ah PARK ; Jong Min LEE ; Seong Hye CHOI
Dementia and Neurocognitive Disorders 2019;18(4):138-148
BACKGROUND AND PURPOSE: Cerebral small vessel disease (CSVD) is the most common cause of vascular dementia and a major contributor to mixed dementia. CSVD is characterized by progressive cerebral white matter changes (WMC) due to chronic low perfusion and loss of autoregulation. In addition to its antiplatelet effect, cilostazol exerts a vasodilating effect and improves endothelial function. This study aims to compare the effects of cilostazol and aspirin on changes in WMC volume in CSVD.METHODS: The comparison study of Cilostazol and aspirin on cHAnges in volume of cerebral smaLL vEssel disease white matter chaNGEs (CHALLENGE) is a double blind, randomized trial involving 19 hospitals across South Korea. Patients with moderate or severe WMC and ≥ 1 lacunar infarction detected on brain magnetic resonance imaging (MRI) are eligible; the projected sample size is 254. Participants are randomly assigned to a cilostazol or aspirin group at a 1:1 ratio. Cilostazol slow release 200 mg or aspirin 100 mg are taken once daily for 2 years. The primary outcome measure is the change in WMC volume on MRI from baseline to 104 weeks. Secondary imaging outcomes include changes in the number of lacunes and cerebral microbleeds, fractional anisotropy and mean diffusivity on diffusion tensor imaging, and brain atrophy. Secondary clinical outcomes include all ischemic strokes, all vascular events, and changes in cognition, motor function, mood, urinary symptoms, and disability.CONCLUSIONS: CHALLENGE will provide evidence to support the selection of long-term antiplatelet therapy in CSVD.TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01932203
Anisotropy
;
Aspirin
;
Atrophy
;
Brain
;
Cerebral Small Vessel Diseases
;
Cognition
;
Dementia
;
Dementia, Vascular
;
Diffusion Tensor Imaging
;
Homeostasis
;
Humans
;
Korea
;
Magnetic Resonance Imaging
;
Outcome Assessment (Health Care)
;
Perfusion
;
Sample Size
;
Stroke
;
Stroke, Lacunar
;
White Matter
7.Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes.
Milim KIM ; Hyun Jeong KIM ; Yul Ri CHUNG ; Eunyoung KANG ; Eun Kyu KIM ; Se Hyun KIM ; Yu Jung KIM ; Jee Hyun KIM ; In Ah KIM ; So Yeon PARK
Journal of Breast Cancer 2018;21(2):197-205
PURPOSE: Although microinvasive carcinoma is distinct from ductal carcinoma in situ (DCIS), the clinical significance of microinvasion in DCIS remains elusive. The purpose of this study is to evaluate the clinicopathological features and clinical outcomes of microinvasive carcinoma compared with pure DCIS. METHODS: We assessed 613 cases of DCIS and microinvasive carcinoma that were consecutively resected from 2003 to 2014 and analyzed clinicopathological variables, expression of standard biomarkers such as the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), p53, and Ki-67, and tumor recurrence. RESULTS: Among the 613 cases, 136 (22.2%) were classified as microinvasive carcinoma. Microinvasive carcinoma was significantly associated with DCIS with a large extent, high nuclear grade, necrosis, and comedotype architectural pattern. ER and PR expressions were dominantly observed in pure DCIS, whereas positive HER2 status, p53 overexpression, and high Ki-67 proliferation indices were more frequently observed in microinvasive carcinoma. Lymph node metastasis was found in only four cases of microinvasive carcinoma with multifocal microinvasion. In the multivariate analysis, DCIS with a large extent, comedo-type architectural pattern, and negative ER status were found to be independent predictors of microinvasion. During follow-up, 12 patients had ipsilateral breast recurrence, and no differences in recurrence rates were observed between patients with DCIS and those with microinvasive carcinoma. The triple-negative subtype was the only factor that was associated with tumor recurrence. CONCLUSION: Microinvasive carcinomas are distinct from DCIS in terms of clinicopathological features and biomarker expressions but are similar to DCIS in terms of clinical outcomes. Our results suggest that microinvasive carcinoma can be treated and followed up as pure DCIS.
Biomarkers
;
Breast
;
Breast Neoplasms
;
Carcinoma, Ductal*
;
Carcinoma, Intraductal, Noninfiltrating*
;
Estrogens
;
Follow-Up Studies
;
Humans
;
Lymph Nodes
;
Multivariate Analysis
;
Necrosis
;
Neoplasm Metastasis
;
Receptor, Epidermal Growth Factor
;
Receptors, Progesterone
;
Recurrence
;
Triple Negative Breast Neoplasms
8.Comparison of self-reported and accelerometer-assessed measurements of physical activity according to socio-demographic characteristics in Korean adults.
Seung Won LEE ; Jee Seon SHIM ; Bo Mi SONG ; Ho Jae LEE ; Hye Yoon BAE ; Ji Hye PARK ; Hye Rin CHOI ; Jae Won YANG ; Ji Eun HEO ; So Mi Jemma CHO ; Ga Bin LEE ; Diana Huanan HIDALGO ; Tae Hoon KIM ; Kyung Soo CHUNG ; Hyeon Chang KIM
Epidemiology and Health 2018;40(1):e2018060-
OBJECTIVES: Previous studies have shown relatively low correlations between self-reported and accelerometer-assessed physical activity (PA). However, this association differs by socio-demographic factors, and this relationship has not been fully investigated in the general population. Thus, we investigated the correlation between self-reported and accelerometer-assessed PA and whether it differed by demographic and socioeconomic factors among the Korean general population. METHODS: This cross-sectional study included 623 participants (203 men and 420 women) aged 30 to 64 years, who completed a PA questionnaire and wore a wrist-worn accelerometer on the non-dominant wrist for 7 days. We examined the agreement for metabolic equivalent task minutes per week (MET-min/wk) between the 2 measures and calculated Spearman correlation coefficients according to demographic and socioeconomic factors. RESULTS: The kappa coefficient between tertiles of self-reported and accelerometer-assessed total MET-min/wk was 0.16 in the total population, suggesting overall poor agreement. The correlation coefficient between the 2 measurements was 0.26 (p < 0.001) in the total population, and the correlation tended to decrease with increasing age (p for trend < 0.001) and depression scores (p for trend < 0.001). CONCLUSION: We found a low correlation between self-reported and accelerometer-assessed PA among healthy Korean adults, and the correlation decreased with age and depression score. When studying PA using accelerometers and/or questionnaires, age and depression need to be considered, as should differences between self-reported and accelerometer-assessed PA.
Adult*
;
Cross-Sectional Studies
;
Depression
;
Humans
;
Korea
;
Male
;
Metabolic Equivalent
;
Motor Activity*
;
Socioeconomic Factors
;
Wrist
9.In-bag power morcellation technique in single-port laparoscopic myomectomy.
Young Bin WON ; Hyun Jin LEE ; Kyung Jin EOH ; Young Shin CHUNG ; Yong Jae LEE ; Seon Hee PARK ; Jee Whan KIM ; Jung Yoon LEE ; Eun Ji NAM ; Sunghoon KIM ; Young Tae KIM ; Sang Wun KIM
Obstetrics & Gynecology Science 2018;61(2):267-273
OBJECTIVE: This study introduces and evaluates the feasibility, safety, and surgical outcomes of the in-bag power morcellation technique during single-port assisted (SPA) laparoscopic myomectomy in comparison with manual scalpel morcellation. METHODS: This is a retrospective review of a total of 58 patients who underwent SPA laparoscopic myomectomy employing in-bag power morcellation (n=27) or manual scalpel morcellation (n=31), performed between December 2014 and December 2016. Surgical outcomes, including total operation time, estimated blood loss, postoperative hemoglobin changes, postoperative hospital stay, postoperative pain (visual analog scale), perioperative and postoperative complications were evaluated. RESULTS: The demographics and patient characteristics were similar between both groups. The median patient age was 34 years and median body mass index was 20.84 kg/m2. The median specimen weight was 110 g. The median operating time was 138 minutes. The median estimated blood loss was 50 mL and the median postoperative hemoglobin change was 2.2 g/dL. The median postoperative hospital stay was 2 days and the median postoperative pain scores were 5 after 6 hours, 3 after 24 hours, and 2 after 48 hours. Occult malignancy was not identified in any patients. There were no intraoperative complications such as LapBag ruptures or gross spillage. CONCLUSION: In-bag power morcellation for SPA laparoscopic myomectomy is feasible and safe, minimizing the risks of open power morcellation. There were also no statistically significant differences in surgical outcomes.
Body Mass Index
;
Demography
;
Humans
;
Intraoperative Complications
;
Laparoscopy
;
Length of Stay
;
Minimally Invasive Surgical Procedures
;
Morcellation*
;
Pain, Postoperative
;
Postoperative Complications
;
Postoperative Hemorrhage
;
Retrospective Studies
;
Rupture
10.Invasive Lobular Carcinoma: Detection and Multiplicity with Multimodalities.
In Hye CHAE ; Eun Suk CHA ; Jee Eun LEE ; Jeoung Hyun KIM ; Bom Sahn KIM ; Jin CHUNG
The Ewha Medical Journal 2018;41(2):27-34
OBJECTIVES: We aimed to compare the diagnostic performances of digital mammography (DM), digital breast tomosynthesis (DBT), ultrasound (US), magnetic resonance imaging (MRI), breast specific gamma imaging (BSGI) and/or positron emission tomography/computed tomography (PET/CT) for the detection of invasive lobular carcinoma (ILC). METHODS: Index ILCs and multifocal/multicentric (multiple) ILCs were analyzed using various imaging modalities. The final surgical pathology was regarded as the reference standard. The detection rate for index cancers and the diagnostic performance for multiple ILCs per breast were evaluated. RESULTS: Seventy-eight ILCs in 76 women were enrolled. Twenty-six breasts had multiple ILCs. DM (n=72), DBT (n=15), US (n=77), MRI (n=76), BSGI (n=50), and /or PET/CT (n=74) were performed. For index cancer, the detection rate was 100% for DBT, US, and MRI. For multiple ILCs, the sensitivity was 100% for DBT and MRI (P<0.001). The diagnostic accuracy for multiple ILCs were 73.3% for DBT and 73.0% for PET/CT (P=0.460). CONCLUSION: DBT was the most accurate imaging modality for both index and multiple ILCs. PET/CT was also valuable for multiple ILCs, whereas DM and BSGI showed relatively low diagnostic performances. DBT and PET/CT have promising roles in the diagnosis of multiple ILCs.
Breast
;
Carcinoma, Lobular*
;
Diagnosis
;
Electrons
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Mammography
;
Pathology, Surgical
;
Positron-Emission Tomography
;
Positron-Emission Tomography and Computed Tomography
;
Ultrasonography

Result Analysis
Print
Save
E-mail